Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Abstract Background The long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) was recently approved for maintenance treatment of bipolar I disorder (BP-I). The purpose of this study was to evaluate the safety, tolerability, and efficacy of AOM 400 as long-term maintenance t...

Full description

Bibliographic Details
Main Authors: Joseph R. Calabrese, Na Jin, Brian Johnson, Pedro Such, Ross A. Baker, Jessica Madera, Peter Hertel, Jocelyn Ottinger, Joan Amatniek, Hiroaki Kawasaki
Format: Article
Language:English
Published: SpringerOpen 2018-06-01
Series:International Journal of Bipolar Disorders
Subjects:
Aripiprazole once-monthly
Bipolar I disorder
Maintenance treatment
Safety
Patient satisfaction
Online Access:http://link.springer.com/article/10.1186/s40345-018-0122-z

Internet

http://link.springer.com/article/10.1186/s40345-018-0122-z

Similar Items